topic

581 Effects of acoustic immune priming with low-intensity focused ultrasound (LOFU) and trabectedin on a murine model of osteosarcoma
Shannon Keisling

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A348-A349; DOI: 10.1136/jitc-2020-SITC2020.0581
641 Incidence and risk factors for stroke associated with immune checkpoint inhibitor therapy in cancer patients using real-world clinical data
Prantesh Jain, Jahir Gutierrez, Avirup Guha, Chhavi Jain, Nirav Patil, Tingke Shen, Ilya Stanevich, Ankit Mangla, Marcos De Lima, Jill Barnholtz-Sloan, Afshin Dowlati

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A384-A385; DOI: 10.1136/jitc-2020-SITC2020.0641
642 Retrospective review of pulmonary pathology associated with chimeric antigen receptor T cell therapy
Jing Du, David Woolston, Kimberly Costas, Alexandre Hirayama, Cameron Turtle, Cecilia Yeung

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A385-A386; DOI: 10.1136/jitc-2020-SITC2020.0642
645 Preclinical development of a novel colon-targeted therapeutic for the treatment of immune checkpoint inhibitor (ICI)-colitis
Nazli Dizman, Milton L Greenberg, Andrew C Newman, Jonathan Skupsky, JoAnn Hsu, Zeynep Zengin, Nicholas Salgia, Luis Meza, Neal Chawla, Sabrina Salgia, Jasnoor Malhotra, Sumanta Pal

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A387; DOI: 10.1136/jitc-2020-SITC2020.0645
649 Incidence of thromboembolism (TE) in patients with melanoma receiving immune checkpoint inhibitor (ICI) therapy and its adverse impact on survival
Tamara Sussman, Joanna Roopkumar, Hong Li, Keith McCrae, Pauline Funchain, Alok Khorana

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A390-A391; DOI: 10.1136/jitc-2020-SITC2020.0649
652 Early outcomes of an app acute checkpoint inhibitor (CPI) care clinic
Lisa Kottschade, Casey Fazer, Anna Schwecke

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A391; DOI: 10.1136/jitc-2020-SITC2020.0652
658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases
Sabina Sandigursky, Safa Houssein, Xerxes Pundole, Elizaveta Efuni, Samuel Cytryn, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Chantal Saberian, Mehmet Altan, Maria Suarez-Almazor, Jeffrey Weber, Adi Diab, Noha Abdel-Wahab

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A395; DOI: 10.1136/jitc-2020-SITC2020.0658
663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
Shameer Khader, Youyi Zhang, Daniel Jackson, Kirsty Rhodes, Imran Khan Anwer Neelufer, Sreenath Nampally, Andrzej Prokop, Emmette Hutchison, Jiabu Ye, Feng Liu, Antony Sabin, James Weatherall, Cristina Duran, Renee Iacona, Faisal Khan, Pralay Mukhopadhyay

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A398; DOI: 10.1136/jitc-2020-SITC2020.0663
664 Applying advanced data analysis to immunotherapy drug discovery for Uveal Melanoma
Sarah Kolitz, Yoonjeong Cha, Sailaja Battula, Rebecca Kusko, Benjamin Zeskind, Howard Kaufman

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A398-A399; DOI: 10.1136/jitc-2020-SITC2020.0664
675 Oxygen concentration alters natural killer cell phenotype and function in the solid tumor microenvironment
Upasana Sunil Arvindam, Phillipa Kennedy, Brianna Ettestad, Peter Hinderlie, Gwen Phung, James Lim, Jeff Miller, Martin Felices

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A405-A406; DOI: 10.1136/jitc-2020-SITC2020.0675

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages